Chronic granulomatous disease. Diagnosis by the dihydrorhodamine assay

Diana Sanabria1, Vivian Giménez1, Celia Martínez de Cuéllar2

  • 1Departamento de Inmunología, Instituto de Investigaciones en ciencias de la Salud, Universidad Nacional de Asunción, Paraguay.

Insights

The dihydrorhodamine (DHR) assay identified three pediatric Chronic Granulomatous Disease (CGD) cases and five carriers in Paraguay. This study provides crucial diagnostic information and insights into CGD inheritance patterns.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Chronic Granulomatous Disease (CGD) involves altered neutrophil oxidative function with X-linked and autosomal recessive inheritance patterns.
  • The dihydrorhodamine (DHR) assay is a key diagnostic tool for CGD, carrier detection, and determining inheritance patterns.

Purpose of the Study:

  • To diagnose CGD in children presenting with recurrent infections using the DHR assay.
  • To evaluate female relatives for carrier status and elucidate inheritance patterns in suspected CGD cases.

Main Methods:

  • The DHR assay was performed on 107 pediatric patients (<18 years) with suspected CGD and 6 female relatives.
  • Neutrophil stimulation index (SI) was measured to assess DHR assay results.

Main Results:

  • The DHR assay detected three CGD cases (two likely X-linked, one AR CGD) and identified five carriers among female relatives.
  • A complete DHR shift was observed in 101/107 children, while 2/107 showed no shift and one had a slight shift.

Conclusions:

  • The DHR assay successfully identified CGD cases and carriers, providing essential diagnostic information in Paraguay.
  • This study marks the first use of the DHR assay in Paraguay for CGD diagnosis and carrier screening, offering insights into inheritance patterns.
Abstract

Related Concept Videos